Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-14 6:11 pm Purchase |
2024-12-31 | 13G | Applied Therapeutics, Inc. APLT |
Venrock Healthcare Capital Partners III, L.P. | 11,805,301 9.900% |
149,236 (+1.28%) |
Filing History |
| 2025-02-14 6:10 pm Unchanged |
2024-12-31 | 13G | Adverum Biotechnologies, Inc. ADVM |
Venrock Healthcare Capital Partners III, L.P. | 0 0.000% |
0 (Unchanged) |
Filing History |
| 2025-02-14 6:09 pm Sale |
2024-12-31 | 13G | 4D Molecular Therapeutics, Inc. FDMT |
Venrock Healthcare Capital Partners III, L.P. | 2,952,371 6.400% |
-1,447,629 (-32.90%) |
Filing History |
| 2025-02-14 6:08 pm Purchase |
2024-12-31 | 13G | Praxis Precision Medicines, Inc. PRAX |
Venrock Healthcare Capital Partners III, L.P. | 1,190,340 6.100% |
283,854 (+31.31%) |
Filing History |
| 2025-02-14 6:06 pm Unchanged |
2024-12-31 | 13G | Spyre Therapeutics, Inc. SYRE |
Venrock Healthcare Capital Partners III, L.P. | 2,685,448 4.600% |
0 (Unchanged) |
Filing History |
| 2025-02-14 6:05 pm Unchanged |
2024-12-31 | 13G | Viridian Therapeutics, Inc. VRDN |
Venrock Healthcare Capital Partners III, L.P. | 3,575,309 4.500% |
0 (Unchanged) |
Filing History |
| 2025-02-03 7:43 pm Purchase |
2025-01-30 | 13G | Applied Therapeutics, Inc. APLT |
Venrock Healthcare Capital Partners III, L.P. | 5,012,796 10.100% |
5,012,796 (New Position) |
Filing History |
| 2024-12-04 4:15 pm Purchase |
2024-11-26 | 13G | Cidara Therapeutics, Inc. CDTX |
Venrock Healthcare Capital Partners III, L.P. | 1,129,097 9.990% |
1,129,097 (New Position) |
Filing History |
| 2024-11-14 5:52 pm Purchase |
2024-09-30 | 13G | Zura Bio Limited ZURA |
Venrock Healthcare Capital Partners III, L.P. | 6,853,600 9.990% |
453,981 (+7.09%) |
Filing History |
| 2024-11-14 5:52 pm Sale |
2024-09-30 | 13G | Viridian Therapeutics, Inc. VRDN |
Venrock Healthcare Capital Partners III, L.P. | 3,575,309 5.500% |
-1,980,259 (-35.64%) |
Filing History |
| 2024-11-14 5:51 pm Sale |
2024-09-30 | 13G | Terns Pharmaceuticals, Inc. TERN |
Venrock Healthcare Capital Partners III, L.P. | 3,516,889 4.990% |
-980,228 (-21.80%) |
Filing History |
| 2024-11-14 5:51 pm Sale |
2024-09-30 | 13G | Taysha Gene Therapies, Inc. TSHA |
Venrock Healthcare Capital Partners III, L.P. | 9,000,000 4.400% |
-1,412,872 (-13.57%) |
Filing History |
| 2024-11-14 5:50 pm Sale |
2024-09-30 | 13G | Spyre Therapeutics, Inc. SYRE |
Venrock Healthcare Capital Partners III, L.P. | 2,685,448 5.300% |
-1,049,066 (-28.09%) |
Filing History |
| 2024-11-14 5:50 pm Purchase |
2024-09-30 | 13G | Praxis Precision Medicines, Inc. PRAX |
Venrock Healthcare Capital Partners III, L.P. | 906,486 5.000% |
82,860 (+10.06%) |
Filing History |
| 2024-11-14 5:49 pm Purchase |
2024-09-30 | 13G | Oruka Therapeutics, Inc. ORKA |
Venrock Healthcare Capital Partners III, L.P. | 3,541,941 9.990% |
3,541,941 (New Position) |
Filing History |
| 2024-11-14 5:49 pm Purchase |
2024-09-30 | 13G | Ocular Therapeutix, Inc. OCUL |
Venrock Healthcare Capital Partners III, L.P. | 13,760,200 8.700% |
5,984,440 (+76.96%) |
Filing History |
| 2024-11-14 5:48 pm Purchase |
2024-09-30 | 13G | Enliven Therapeutics, Inc. ELVN |
Venrock Healthcare Capital Partners III, L.P. | 4,026,331 8.500% |
1,071,429 (+36.26%) |
Filing History |
| 2024-11-14 5:48 pm Purchase |
2024-09-30 | 13G | enGene Holdings Inc. Common Stock ENGN |
Venrock Healthcare Capital Partners III, L.P. | 3,565,841 8.100% |
1,000,000 (+38.97%) |
Filing History |
| 2024-11-14 5:47 pm Purchase |
2024-09-30 | 13G | Applied Therapeutics, Inc. APLT |
Venrock Healthcare Capital Partners III, L.P. | 11,656,065 9.990% |
3,778,248 (+47.96%) |
Filing History |
| 2024-11-14 5:47 pm Purchase |
2024-09-30 | 13G | Dianthus Therapeutics, Inc. DNTH |
Venrock Healthcare Capital Partners III, L.P. | 1,744,373 5.900% |
816,667 (+88.03%) |
Filing History |